Showing results (101-110 of 267) with videos related to

Sort By:
Pageof 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2020
Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent YearsAli Bazarbachi, Christoph Schmid, Myriam Labopin, et al.
Journal of Medical Virology|February 19, 2021
An investigation of the potential association between gastrointestinal viral and bacterial infection and development of intestinal acute graft versus host disease following allogeneic hematopoietic stem cell transplantationFelipe Bueno, Eliseo Albert, Estela Giménez, et al.
Cancer Chemotherapy and Pharmacology|September 29, 2007
Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC)Fernando Rivera, M Eugenia Vega-Villegas, Marta López-Brea, et al.
Clinical Case Reports|November 21, 2017
Allogeneic hematopoietic cell transplantation in an adult patient with Glanzmann thrombastheniaAna R Cid, Pau Montesinos, Isabel Sánchez-Guiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute LeukemiaArnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.
Transplantation and Cellular Therapy|October 10, 2023
Thiotepa-Based Regimens Are Valid Alternatives to Total Body Irradiation-Based Reduced-Intensity Conditioning Regimens in Patients with Acute Lymphoblastic Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationGiorgia Battipaglia, Myriam Labopin, Stephan Mielke, et al.
Bone Marrow Transplantation|August 8, 2023
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMTJaime Sanz, Myriam Labopin, Thomas Pabst, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 11, 2020
Kinetics of Torque Teno virus DNA in stools may predict occurrence of acute intestinal graft versus host disease early after allogeneic hematopoietic stem cell transplantationFelipe Bueno, Eliseo Albert, José Luis Piñana, et al.
Bone Marrow Transplantation|May 13, 2025
Addition of mycophenolate mofetil to a calcineurin inhibitor and post-transplant cyclophosphamide results in lower incidence of extensive chronic graft-versus-host disease in HLA-matched allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in complete remission: a matched-pair analysis on behalf of the Acute Leukemia Working Party of the EBMTGiorgia Battipaglia, Myriam Labopin, Aleksandr Kulagin, et al.
Transplantation and Cellular Therapy|July 14, 2023
Reduced Incidence of Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation with Calcineurin-Free Graft-versus-Host Disease ProphylaxisAitana Balaguer-Roselló, Sara Gil-Perotín, Juan Montoro, et al.
Pageof 27